Dr. Franchin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
350 Community Drive
Manhasset, NY 11030Phone+1 516-562-3836Fax+1 516-562-2953
Education & Training
- New York Presbyterian Hospital (Cornell Campus)Fellowship, Rheumatology, 2003 - 2006
- Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Fellowship, Rheumatology, 2003 - 2005
- Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Residency, Internal Medicine, 2001 - 2003
- Federal University of Minas GeraisClass of 1993
Certifications & Licensure
- NY State Medical License 2004 - 2026
- American Board of Internal Medicine Rheumatology
Awards, Honors, & Recognition
- Fellow American College of Rheumatology
Clinical Trials
- Efficacy and Safety of Belimumab in Black Race Patients With Systemic Lupus Erythematosus (SLE) Start of enrollment: 2013 Feb 19
- Nelfinavir in Systemic Lupus Erythematosus Start of enrollment: 2014 Sep 01
- Efficacy and Safety of Anifrolumab Compared to Placebo in Adult Subjects With Active Systemic Lupus Erythematosus Start of enrollment: 2015 Jul 09
- Join now to see all
Publications & Presentations
PubMed
- 28 citationsThe effect of granulocyte colony-stimulating factor on oral mucositis in head and neck cancer patients treated with hyperfractionated radiotherapy.Maurizio Mascarin, Giovanni Franchin, Emilio Minatel, Carlo Gobitti, Renato Talamini
Oral Oncology. 1999-03-01 - 29 citationsPrognostic Nutritional Index Predicts Toxicity in Head and Neck Cancer Patients Treated with Definitive Radiotherapy in Association with Chemotherapy.Giuseppe Fanetti, Jerry Polesel, Elisabetta Fratta, Elena Muraro, Valentina Lupato
Nutrients. 2021-04-13 - 54 citationsRadical pleurectomy/decortication followed by high dose of radiation therapy for malignant pleural mesothelioma. Final results with long-term follow-upEmilio Minatel, Marco Trovo, Jerry Polesel, Tania Baresic, Alessandra Bearz
Lung Cancer. 2014-01-01
Press Mentions
- IRAK 4 Inhibitor (PF-06650833) in Hospitalized Patients with COVID-19 Pneumonia and Exuberant InflammationJune 22nd, 2021
Other Languages
- Italian, Portuguese, Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: